Update on male hormonal contraception
Despite increases in female contraceptive options, 40–45% of pregnancies across the world are still unplanned. While several effective female contraceptive methods have been developed, contraceptive choices for men are still limited to the male condom with its high failure rates and to vasectomies,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-03-01
|
| Series: | Therapeutic Advances in Endocrinology and Metabolism |
| Online Access: | https://doi.org/10.1177/2042018819834846 |
| _version_ | 1811210404699832320 |
|---|---|
| author | Giulia Gava Maria Cristina Meriggiola |
| author_facet | Giulia Gava Maria Cristina Meriggiola |
| author_sort | Giulia Gava |
| collection | DOAJ |
| description | Despite increases in female contraceptive options, 40–45% of pregnancies across the world are still unplanned. While several effective female contraceptive methods have been developed, contraceptive choices for men are still limited to the male condom with its high failure rates and to vasectomies, which are invasive and not reliably reversible. Several studies have demonstrated a great interest among men and women for effective, reversible, and safe male contraceptive methods. Over the years, numerous studies have been performed to develop male hormonal and nonhormonal safe and effective contraceptives. A variety of new molecules are under development as oral or transdermal hormonal contraceptives for men demonstrating few side effects. In our overpopulated world, the development and commercialization of a male contraceptive method that will allow both men and women to take an active role in family planning is mandatory and further research on this topic is required. |
| first_indexed | 2024-04-12T04:55:02Z |
| format | Article |
| id | doaj.art-bf2323661bdd4763a254209bdedcadf9 |
| institution | Directory Open Access Journal |
| issn | 2042-0196 |
| language | English |
| last_indexed | 2024-04-12T04:55:02Z |
| publishDate | 2019-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Endocrinology and Metabolism |
| spelling | doaj.art-bf2323661bdd4763a254209bdedcadf92022-12-22T03:47:10ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01962019-03-011010.1177/2042018819834846Update on male hormonal contraceptionGiulia GavaMaria Cristina MeriggiolaDespite increases in female contraceptive options, 40–45% of pregnancies across the world are still unplanned. While several effective female contraceptive methods have been developed, contraceptive choices for men are still limited to the male condom with its high failure rates and to vasectomies, which are invasive and not reliably reversible. Several studies have demonstrated a great interest among men and women for effective, reversible, and safe male contraceptive methods. Over the years, numerous studies have been performed to develop male hormonal and nonhormonal safe and effective contraceptives. A variety of new molecules are under development as oral or transdermal hormonal contraceptives for men demonstrating few side effects. In our overpopulated world, the development and commercialization of a male contraceptive method that will allow both men and women to take an active role in family planning is mandatory and further research on this topic is required.https://doi.org/10.1177/2042018819834846 |
| spellingShingle | Giulia Gava Maria Cristina Meriggiola Update on male hormonal contraception Therapeutic Advances in Endocrinology and Metabolism |
| title | Update on male hormonal contraception |
| title_full | Update on male hormonal contraception |
| title_fullStr | Update on male hormonal contraception |
| title_full_unstemmed | Update on male hormonal contraception |
| title_short | Update on male hormonal contraception |
| title_sort | update on male hormonal contraception |
| url | https://doi.org/10.1177/2042018819834846 |
| work_keys_str_mv | AT giuliagava updateonmalehormonalcontraception AT mariacristinameriggiola updateonmalehormonalcontraception |